Henderson, NV – October 21, 2014 – United Health Products Inc. (OTCQB: UEEC) announced that its Canadian distributor Medicom® has placed an initial sampling and stocking order for the US and Canadian Dental Markets. Medicom®, headquartered in Montreal, Quebec with operations in over 50 countries, is a globally recognized manufacturer and supplier to the Dental and Health Care Industries.
Military Protocol Swine test
United Health Products Inc. will be conducting a series of tests next week at Spring Valley Laboratories, a military approved GLP compliant CRO research facility. The purpose of the tests is to evaluate the efficacy of HemoStyp® Trauma Gauze in an uncontrolled hemorrhage environment. The test will be performed on swine to simulate wounds associated with battle and injuries sustained from accidents. Representatives from various agencies including the US Military have been invited to attend. The results and findings of the test will be presented in a white paper and published.
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com
Medicom® is a private Canadian company founded by Ronald Reuben in 1988. Medicom® is a global health care company headquartered in Montreal, Quebec with operations in over 50 countries, including Canada, the United States, the Netherlands, France, China and Taiwan. Ronald Reuben, Founder and Chief Executive Officer, was the winner of the world’s most prestigious business award for entrepreneurs, EY Entrepreneur of the Year in 2013 award in the Science category for Quebec. www.medicom.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
United Health Products, Inc.